WOODBURY et al., 1945 - Google Patents
INFLUENCE OF NEOSTIGMINE METHYLSULFATE ON PREECLAMPTIC PATIENTS: AND CHOLINESTERASE ACTIVITY OF PLACENTAS FROM NORMAL AND …WOODBURY et al., 1945
- Document ID
- 12113264398518810061
- Author
- WOODBURY R
- ABREU B
- TORPIN R
- FRIED P
- Publication year
- Publication venue
- Journal of the American Medical Association
External Links
Snippet
A number of reports 1 state that the normal pregnant woman has some substance in her blood which will neutralize posterior pituitary injection and that an injection of this substance into preeclamptic patients will occasionally initiate the onset of convulsions. The …
- 230000000694 effects 0 title abstract description 29
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sharkey et al. | Infection of the urinary tract in diabetes | |
Clay et al. | Reactions to total dose intravenous infusion of iron dextran (Imferon) | |
WILKINS et al. | EXTENSIVE LABORATORY STUDIES OF A PATIENT WITH PHEOCHROMOCYTOMA BEFORE AND AFTER SUCCESSFUL OPERATION: With a Note on the Trial of Piperidylmethyl Benzodioxane to Differentiate Such Conditions from Essential Hypertensive Vascular Disease | |
Terry | Ocular maldevelopment in extremely premature infants: Retrolental fibroplasia: VI. General consideration | |
THOMPSON et al. | Precocious sexual development from an anterior pituitarylike principle | |
WOODBURY et al. | INFLUENCE OF NEOSTIGMINE METHYLSULFATE ON PREECLAMPTIC PATIENTS: AND CHOLINESTERASE ACTIVITY OF PLACENTAS FROM NORMAL AND PREECLAMPTIC PATIENTS | |
Overman et al. | EFFECTIVENESS OF SYNTHETIC WATERSOLUBLE VITAMIN K PREPARATIONS IN BISHYDROXYCOUMARIN-INDUCED HYPOPROTHROMBINEMIA | |
FALLS et al. | Effect of antepartum vitamin K on retinal hemorrhage | |
Suzuki et al. | Anaerobic change of bloody CSF in subarachnoid haemorrhage. Its relation to cerebral vasospasm | |
O'LEARY et al. | Portal Cirrhosis Associated with Chronic Inorganic Arsenical Poisoning: Report of Two Cases | |
De Lee et al. | The Year Book of Obstetrics and Gynecology... | |
WILHELMI | Congenital median bars occurring in twins | |
Davis et al. | Toxemia of pregnancy: eight hundred and seventy-nine cases with convulsions at the New York Lying-in Hospital | |
Martin | The Surgical treatment of wounds and obstructions of the intestines | |
MASSON | Myomectomy, hysterectomy and radiotherapy in fibromyoma of uterus | |
BASS | THE TREATMENT OF MALARIA: WITH SOME REFERENCE TO RECENTLY PROMOTED NEW REMEDIES | |
Bartholomew | ABRUPTIO PLACENTAE FOLLOWING ACUTE PLACENTAL INFARCT: CESAREAN SECTION; STAPHYLOCOCCUS AUREUS SEPTICEMIA; RECOVERY FOLLOWING TRANSFUSIONS FROM IMMUNE DONORS | |
Cox et al. | rise on right upper quadrant compression, slightly prolonged arm-to-lung time, and considerably prolonged lung | |
Miller | The action of quinine on the pregnant uterus: Acton: The Lancet, London, 1921, cc, 1, 216 | |
Trimble et al. | Control of pulmonary hemorrhage by intravenous use of pituitrin | |
Defectives et al. | Alabama Medical Association Journal, Montgomery | |
Sadlier | SOME COMPLICATIONS OF UTERINE FIBROIDS DEMANDING EARLY DIAGNOSIS AND IMMEDIATE OPERATION. | |
WOOD Jr | The drug treatment of uterine hemorrhages | |
Whittier | The Treatment of Benign Lesions of the Cervix Uteri | |
Wiggers | Vasodilatation Following Sympathetic Neurectomy.—Dur¬ ing the last three years, approximately fifty patients with |